These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21469604)

  • 1. Determination of free cisplatin in medium by differential pulse polarography after ultrasound and cisplatin treatment of a cancer cell culture.
    Bernard V; Fojt L; Skorpíková J; Mornstein V
    Indian J Biochem Biophys; 2011 Feb; 48(1):59-62. PubMed ID: 21469604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological effects of combined ultrasound and cisplatin treatment on ovarian carcinoma cells.
    Bernard V; Skorpíková J; Mornstein V; Slaninová I
    Ultrasonics; 2010 Mar; 50(3):357-62. PubMed ID: 19740505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound and cisplatin combined treatment of human melanoma cells A375--the study of sonodynamic therapy.
    Bernard V; Mornstein V; Škorpíková J; Jaroš J
    Ultrasound Med Biol; 2012 Jul; 38(7):1205-11. PubMed ID: 22502893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
    Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
    Kozubík A; Horváth V; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Zák F; Mistr A; Turánek J
    Biochem Pharmacol; 2005 Feb; 69(3):373-83. PubMed ID: 15652229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
    Chen G; Zeller WJ; Todorov DK
    Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro.
    Krieger ML; Eckstein N; Schneider V; Koch M; Royer HD; Jaehde U; Bendas G
    Int J Pharm; 2010 Apr; 389(1-2):10-7. PubMed ID: 20060458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonodynamic therapy--a review of the synergistic effects of drugs and ultrasound.
    Rosenthal I; Sostaric JZ; Riesz P
    Ultrason Sonochem; 2004 Sep; 11(6):349-63. PubMed ID: 15302020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined effect of ultrasound exposure and cisplatin on human ovarian carcinoma cells A2780.
    Bernard V; Skorpíková J; Mornstein V
    Folia Biol (Praha); 2008; 54(3):97-101. PubMed ID: 18647549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
    Andreotti PE; Cree IA; Kurbacher CM; Hartmann DM; Linder D; Harel G; Gleiberman I; Caruso PA; Ricks SH; Untch M
    Cancer Res; 1995 Nov; 55(22):5276-82. PubMed ID: 7585588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.
    Yang X; Xing H; Gao Q; Chen G; Lu Y; Wang S; Ma D
    Gynecol Oncol; 2005 May; 97(2):413-21. PubMed ID: 15863139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells.
    Varma R; Hector S; Greco WR; Clark K; Hawthorn L; Porter C; Pendyala L
    Cancer Chemother Pharmacol; 2007 May; 59(6):711-23. PubMed ID: 17021820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of near field ultrasound on carboplatin treatment of ovarian carcinoma cells.
    Bernard V; Mornstein V; Bourek A
    Indian J Biochem Biophys; 2013 Aug; 50(4):284-8. PubMed ID: 24772947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound increases DNA damage attributable to cisplatin in cisplatin-resistant human ovarian cancer cells.
    Yu T; Yang Y; Liu S; Yu H
    Ultrasound Obstet Gynecol; 2009 Mar; 33(3):355-9. PubMed ID: 19204912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies.
    Williams JI; Weitman S; Gonzalez CM; Jundt CH; Marty J; Stringer SD; Holroyd KJ; Mclane MP; Chen Q; Zasloff M; Von Hoff DD
    Clin Cancer Res; 2001 Mar; 7(3):724-33. PubMed ID: 11297269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.
    Cafaggi S; Russo E; Stefani R; Leardi R; Caviglioli G; Parodi B; Bignardi G; De Totero D; Aiello C; Viale M
    J Control Release; 2007 Aug; 121(1-2):110-23. PubMed ID: 17601625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.